Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey
American Society of Clinical Oncology (ASCO) Annual Meeting, Illinois, United States Of America, 29 - 31 May 2020, pp.13055, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Doi Number: 10.1200/jco.2020.38
- City: Illinois
- Country: United States Of America
- Page Numbers: pp.13055
- Acibadem Mehmet Ali Aydinlar University Affiliated: Yes